manganese has been researched along with Parkinson Disease, Secondary in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (11.11) | 18.7374 |
1990's | 13 (24.07) | 18.2507 |
2000's | 15 (27.78) | 29.6817 |
2010's | 20 (37.04) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gening, LV; Kazachenko, KY; Tarantul, VZ; Zakharcheva, KA | 1 |
Anantharam, V; Ghaisas, S; Harischandra, DS; Jin, H; Kanthasamy, A; Kanthasamy, AG; Kimber, M; Rokad, D; Zamanian, M | 1 |
Anantharam, V; Ay, M; Ghaisas, S; Jin, H; Kanthasamy, A; Kanthasamy, AG; Langley, MR; Luo, J; Palanisamy, BN | 1 |
Antonini, JM; Johnson, C; Krajnak, K; Mercer, R; Miller, GR; Roberts, JR; Sriram, K; Wirth, O | 1 |
Bowler, RM; Casey, SL; Colledge, MA; Kornblith, ES; Lobdell, DT | 1 |
Anantharam, V; Ghaisas, S; Harischandra, DS; Huang, X; Jin, H; Kanthasamy, A; Kanthasamy, AG; Lewis, M; Manne, S; Neal, ML; Panicker, N; Rokad, D; Sarkar, S; Zenitsky, G | 1 |
Afshari, A; Antonini, JM; Chen, BT; Cumpston, A; Cumpston, JL; Frazer, DG; Jackson, M; Jefferson, AM; Keane, MJ; Lin, GX; McKinney, W; Roberts, JR; Schwegler-Berry, D; Sriram, K; Stone, S | 1 |
Checkoway, H; Criswell, SR; Farin, FM; Racette, BA; Searles Nielsen, S; Sheppard, L; Stapleton, PL | 1 |
Sikk, K; Taba, P | 1 |
Fitzgerald, E; Ratner, MH | 1 |
Checkoway, H; Criswell, SR; Racette, BA; Searles Nielsen, S; Seixas, N; Sheppard, L; Warden, MN | 1 |
Schuh, MJ | 1 |
Aschner, M; Erikson, KM; Hernández, EH; Herrero Hernández, E; Tjalkens, R | 1 |
Roth, JA | 2 |
Doney, BC; Lucchini, RG; Martin, CJ | 1 |
Guilarte, TR | 2 |
Furbee, B | 1 |
Aschner, M; Criswell, SR; Dydak, U; Guilarte, TR; Racette, BA; Zheng, W | 1 |
Broberg, K; Covolo, L; Haddad, AA; Lucchini, RG; Rentschler, G; Zoni, S | 1 |
Bornhorst, J; Galla, HJ; Hüwel, S; Karst, U; Schwerdtle, T; Wehe, CA | 1 |
Jiang, Y; Mo, X; Rutchik, JS; Zheng, W | 1 |
Aquilonius, SM; Asser, A; Bergquist, J; Eriksson, SL; Haldre, S; Paris, M; Petterson, J; Roose, Ä; Sikk, K; Taba, P | 1 |
Chung, HK; Jeon, B; Kim, HK; Kim, JM; Kim, JW; Kim, Y; Lee, CR; Lee, DS; Lee, JH; Yang, SO; Yoo, CI | 1 |
Kaiser, J | 2 |
Chu, NS; Huang, CC; Lu, CS; Weng, YH; Yen, TC | 1 |
Chu, NS | 1 |
Kobayashi, S; Maesato, K; Moriya, H; Negishi, K; Ohtake, T; Oka, M; Okamoto, K | 1 |
Aldins, P; Donaghy, M; Eksteina, I; Liguts, V; Logina, I; Mārtinsone, I; Platkājis, A; Rozentāle, B; Stepens, A; Tērauds, E | 1 |
Atadzhanov, M | 1 |
Chen, KM; Gajdusek, DC; Gibbs, CJ; Iwata, S; Sasajima, K; Tanaka, S; Uebayashi, Y; Yase, Y; Yasui, M; Yoshimasu, F | 1 |
Burns, LJ; Fredstrom, S; Gupta, P; Rogosheske, J | 1 |
Aguilar, MV; Arrieta, FJ; Ayuso-Peralta, L; Cabrera-Valdivia, F; García-Albea, E; Jiménez-Jiménez, FJ; Jorge-Santamaría, A; Molina, JA; Rabasa, M; Vázquez, A | 1 |
Bonifati, V; Fabrizio, E; Meco, G; Vanacore, N | 1 |
Calne, DB; Chu, NS; Huang, CC; Lu, CS; Olanow, W | 1 |
Buchet, JP; Ceulemans, E; Lauwerys, R; Magos, C; Roels, H | 1 |
Calne, DB; Chu, NS; Hochberg, F; Huang, CC; Lilienfeld, D; Lu, CS; Olanow, W | 1 |
Calne, DB; Chen, RS; Chu, NS; Huang, CC; Lu, CS | 1 |
Chiueh, CC; Kim, HG; Mohanakumar, KP; Rauhala, P; Sziráki, I; Yeh, KJ | 1 |
Cheong, HK; Ito, K; Kim, JW; Kim, Y | 1 |
Rajput, AH | 1 |
Arakawa, R; Kumamoto, T; Sato, K; Tsuda, T; Ueyama, H | 1 |
Gerber, GB; Hantson, P; Léonard, A | 1 |
Jenner, P; Kunikowska, G | 1 |
Hagman, M; Johansson, L; Wennberg, A | 1 |
Feldman, RG | 1 |
Hua, MS; Huang, CC | 1 |
Garnett, ES; Lang, AE | 1 |
Chen, JS; Chiang, JR; Huang, CC; Hwang, YH; Lin, JM; Wang, JD | 1 |
Jepsen, JR; Rasmussen, KH | 1 |
Beuche, W; Holzgraefe, M; Kijewski, H; Poser, W | 1 |
McGeer, PL | 1 |
13 review(s) available for manganese and Parkinson Disease, Secondary
Article | Year |
---|---|
Methcathinone "Kitchen Chemistry" and Permanent Neurological Damage.
Topics: Brain; Humans; Manganese; Neuroimaging; Parkinson Disease, Secondary; Propiophenones | 2015 |
Manganese and its role in Parkinson's disease: from transport to neuropathology.
Topics: Animals; Biological Transport; Chelating Agents; Chelation Therapy; Energy Metabolism; Humans; Manganese; Manganese Poisoning; Membrane Transport Proteins; Mice; Mitochondria; Neuroglia; Occupational Exposure; Parkinson Disease, Secondary; Rats; Synaptic Transmission | 2009 |
Are there common biochemical and molecular mechanisms controlling manganism and parkisonism.
Topics: Animals; Cation Transport Proteins; Genetic Predisposition to Disease; Genetic Variation; Globus Pallidus; Humans; Iron; Manganese; Manganese Poisoning; Mice; Occupational Diseases; Occupational Exposure; Parkinson Disease, Secondary; Proton-Translocating ATPases; Rats; Ubiquitin-Protein Ligases | 2009 |
From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure.
Topics: alpha-Synuclein; Basal Ganglia; Environmental Exposure; Globus Pallidus; Humans; Male; Manganese; Manganese Poisoning; Occupational Exposure; Parkinson Disease, Secondary; Proton-Translocating ATPases; Substantia Nigra; Ubiquitin-Protein Ligases; Welding; Workforce | 2009 |
Manganese and Parkinson's disease: a critical review and new findings.
Topics: Animals; Basal Ganglia; Diagnosis, Differential; Environmental Exposure; Humans; Manganese; Manganese Poisoning; Nerve Degeneration; Parkinson Disease; Parkinson Disease, Secondary; Primates | 2010 |
Welding and parkinsonism.
Topics: Humans; Manganese; Manganese Poisoning; Occupational Diseases; Occupational Exposure; Parkinson Disease, Secondary; Welding | 2011 |
Manganese and Parkinson's disease: a critical review and new findings.
Topics: Animals; Humans; Manganese; Neuroimaging; Parkinson Disease, Secondary; Primate Diseases | 2011 |
Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination.
Topics: Biological Transport; Environmental Exposure; Homeostasis; Humans; Manganese; Occupational Diseases; Parkinson Disease, Secondary; Risk Assessment; Tissue Distribution | 2006 |
[Modeling parkinsonism (review)].
Topics: Aluminum; Animals; Carbachol; Cats; Caudate Nucleus; Chlorides; Chlorpromazine; Disease Models, Animal; Globus Pallidus; Humans; Hydroxydopamines; Manganese; Manganese Compounds; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Putamen; Rabbits; Rats; Red Nucleus; Reserpine; Substantia Nigra; Syndrome; Tetanus Toxin; Thalamus; Tungsten; Tungsten Compounds | 1982 |
Extrapyramidal symptoms in a BMT recipient with hyperintense basal ganglia and elevated manganese.
Topics: Basal Ganglia; Bone Marrow Transplantation; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Magnetic Resonance Imaging; Manganese; Middle Aged; Parenteral Nutrition, Total; Parkinson Disease, Secondary | 1995 |
Manganism and idiopathic parkinsonism: similarities and differences.
Topics: Brain; Humans; Manganese; Manganese Poisoning; Movement Disorders; Nervous System Diseases; Parkinson Disease; Parkinson Disease, Secondary | 1994 |
[A case of welder presenting with parkinsonism after chronic manganese exposure].
Topics: Brain; Humans; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Occupational Exposure; Parkinson Disease; Parkinson Disease, Secondary; Welding | 2000 |
Carcinogenicity, mutagenicity and teratogenicity of manganese compounds.
Topics: Abnormalities, Drug-Induced; Adult; Animals; Bacteria; Carcinogenicity Tests; Cricetinae; Female; Fetus; Humans; Infant; Infant, Newborn; Infertility; Male; Mammals; Manganese; Manganese Compounds; Manganese Poisoning; Mice; Middle Aged; Mutagenicity Tests; Neoplasms, Experimental; Occupational Diseases; Parkinson Disease, Secondary; Pregnancy; Rats | 2002 |
41 other study(ies) available for manganese and Parkinson Disease, Secondary
Article | Year |
---|---|
Cells Resistant to Toxic Concentrations of Manganese Have Increased Ability to Repair DNA.
Topics: Cell Line, Tumor; DNA Repair; DNA Replication; Drug Resistance; Female; Humans; Manganese; Models, Biological; Parkinson Disease, Secondary; Poly(ADP-ribose) Polymerases | 2017 |
Environmental neurotoxicant manganese regulates exosome-mediated extracellular miRNAs in cell culture model of Parkinson's disease: Relevance to α-synuclein misfolding in metal neurotoxicity.
Topics: alpha-Synuclein; Cells, Cultured; Dopaminergic Neurons; Exosomes; Humans; Manganese; MicroRNAs; Parkinson Disease, Secondary; Proteostasis Deficiencies | 2018 |
Manganese exposure exacerbates progressive motor deficits and neurodegeneration in the MitoPark mouse model of Parkinson's disease: Relevance to gene and environment interactions in metal neurotoxicity.
Topics: Animals; Behavior, Animal; Cell Line; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Female; Gene-Environment Interaction; Male; Manganese; Mice, Transgenic; Mitochondria; Motor Activity; Oxidative Stress; Parkinson Disease, Secondary; Parkinsonian Disorders; Substantia Nigra | 2018 |
Effects of pulmonary exposure to chemically-distinct welding fumes on neuroendocrine markers of toxicity.
Topics: Air Pollutants, Occupational; Animals; Biomarkers; Chlorides; Hypothalamus; Inhalation Exposure; Male; Manganese; Manganese Compounds; Occupational Exposure; Parkinson Disease, Secondary; Prolactin; Rats; Rats, Sprague-Dawley; Reproduction; Spermatogenesis; Testosterone; Tyrosine 3-Monooxygenase; Welding | 2017 |
Environmental exposure to manganese in air: Tremor, motor and cognitive symptom profiles.
Topics: Aged; Air Pollutants; Cognitive Dysfunction; Environmental Exposure; Female; Gait Disorders, Neurologic; Humans; Hypokinesia; Male; Manganese; Neuropsychological Tests; Ohio; Parkinson Disease, Secondary; Tremor | 2018 |
Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein.
Topics: alpha-Synuclein; Animals; Cell Line; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Exosomes; Manganese; Mice; Parkinson Disease, Secondary; Prions; Protein Aggregation, Pathological | 2019 |
Modifying welding process parameters can reduce the neurotoxic potential of manganese-containing welding fumes.
Topics: Aerosols; Air Pollutants, Occupational; Animals; Body Burden; Brain; Dopaminergic Neurons; Equipment Design; Gene Expression Regulation; Humans; Inhalation Exposure; Male; Manganese; Manganese Poisoning; Parkinson Disease, Secondary; Particle Size; Rats, Sprague-Dawley; Risk Assessment; Solubility; Time Factors; Welding | 2015 |
Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders.
Topics: Adult; Aged; DNA Methylation; Humans; Male; Manganese; Middle Aged; Nitric Oxide Synthase Type II; Occupational Diseases; Occupational Exposure; Parkinson Disease, Secondary; Welding | 2015 |
Understanding of the role of manganese in parkinsonism and Parkinson disease.
Topics: Humans; Manganese; Manganese Poisoning; Parkinson Disease; Parkinson Disease, Secondary; Parkinsonian Disorders | 2017 |
Dose-dependent progression of parkinsonism in manganese-exposed welders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants, Occupational; Confined Spaces; Disease Progression; Female; Humans; Longitudinal Studies; Male; Manganese; Middle Aged; Occupational Diseases; Occupational Exposure; Parkinson Disease, Secondary; Severity of Illness Index; United States; Welding; Young Adult | 2017 |
Possible Parkinson's Disease Induced by Chronic Manganese Supplement Ingestion.
Topics: Adult; Cat's Claw; Dietary Supplements; Dose-Response Relationship, Drug; Eucalyptus; Female; Humans; Manganese; Medication Therapy Management; Parkinson Disease, Secondary; Plant Preparations; Serotonin | 2016 |
Pathophysiology of manganese-associated neurotoxicity.
Topics: Air Pollutants, Occupational; Animals; Aspartic Acid; Brain; Dopamine; gamma-Aminobutyric Acid; Humans; Magnetic Resonance Imaging; Manganese; Manganese Poisoning; Models, Animal; Occupational Diseases; Occupational Exposure; Occupational Health; Parkinson Disease, Secondary; Phenotype; Positron-Emission Tomography; Risk Assessment; Risk Factors | 2012 |
ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese.
Topics: Adolescent; Age Factors; Aged; Aged, 80 and over; Chi-Square Distribution; Child; Cross-Sectional Studies; Environmental Exposure; Environmental Monitoring; Female; Gene-Environment Interaction; Genetic Predisposition to Disease; Humans; Iron; Italy; Linear Models; Male; Manganese; Manganese Poisoning; Middle Aged; Motor Activity; Multivariate Analysis; Neuropsychological Tests; Olfaction Disorders; Parkinson Disease, Secondary; Phenotype; Polymerase Chain Reaction; Proton-Translocating ATPases; Residence Characteristics; Risk Assessment; Risk Factors; Smell; Soil; Soil Pollutants; Spectrometry, X-Ray Emission; Spectrophotometry, Atomic | 2012 |
Impact of manganese on and transfer across blood-brain and blood-cerebrospinal fluid barrier in vitro.
Topics: Animals; Blood-Brain Barrier; Calcium; Cells, Cultured; Chlorides; Ion Transport; Manganese; Manganese Compounds; Models, Biological; Parkinson Disease, Secondary; Swine | 2012 |
How does an occupational neurologist assess welders and steelworkers for a manganese-induced movement disorder? An international team's experiences in Guanxi, China Part II.
Topics: Adult; Aged; Biomarkers; China; Female; Humans; International Cooperation; Magnetic Resonance Imaging; Male; Manganese; Manganese Poisoning; Metallurgy; Middle Aged; Neurology; Occupational Diseases; Occupational Exposure; Occupational Medicine; Parkinson Disease, Secondary; Steel; Welding | 2012 |
Manganese-induced parkinsonism in methcathinone abusers: bio-markers of exposure and follow-up.
Topics: Adolescent; Adult; Biomarkers; Cohort Studies; Estonia; Female; Follow-Up Studies; Hair; Humans; Male; Manganese; Middle Aged; Parkinson Disease, Secondary; Propiophenones; Substance-Related Disorders; Young Adult | 2013 |
Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?
Topics: Causality; Cocaine; Corpus Striatum; Diagnosis, Differential; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; Iodine Radioisotopes; Male; Manganese; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Occupational Exposure; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed, Single-Photon | 2002 |
Manganese: a high-octane dispute.
Topics: Aging; Air Pollutants; Animals; Blood-Brain Barrier; Brain; Canada; Gasoline; Humans; Inhalation Exposure; Iron; Iron Deficiencies; Lung; Manganese; Manganese Poisoning; Maximum Allowable Concentration; Organometallic Compounds; Parkinson Disease, Secondary; Risk Factors; Threshold Limit Values; Toxicity Tests; United States; United States Environmental Protection Agency; Vehicle Emissions | 2003 |
State Court to rule on manganese fume claims.
Topics: Humans; Inhalation Exposure; Jurisprudence; Manganese; Manganese Poisoning; Mississippi; Occupational Diseases; Occupational Exposure; Parkinson Disease, Secondary; Welding | 2003 |
Dopamine transporter binding in chronic manganese intoxication.
Topics: Brain; Chronic Disease; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iron; Male; Manganese; Manganese Poisoning; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Organotechnetium Compounds; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tropanes | 2003 |
Effect of levodopa treatment for parkinsonism in welders: a double-blind study.
Topics: Age of Onset; Brain; Clinical Trials as Topic; Diagnosis, Differential; Diagnostic Errors; Dopamine Agents; Double-Blind Method; Dystonia; Gait Disorders, Neurologic; Humans; Levodopa; Manganese; Manganese Poisoning; Occupational Exposure; Parkinson Disease, Secondary; Tremor; Welding | 2004 |
Manganese-induced Parkinsonism in a patient undergoing maintenance hemodialysis.
Topics: Apiaceae; Basal Ganglia; Chelating Agents; Chelation Therapy; Chlorella; Diabetic Nephropathies; Dietary Supplements; Dysarthria; Edetic Acid; Gait Disorders, Neurologic; Handwriting; Humans; Kidney Failure, Chronic; Magnetic Resonance Imaging; Male; Manganese; Middle Aged; Parkinson Disease, Secondary; Plant Preparations; Renal Dialysis | 2005 |
A Parkinsonian syndrome in methcathinone users and the role of manganese.
Topics: Acquired Immunodeficiency Syndrome; Adult; Age of Onset; Drug Contamination; Female; Globus Pallidus; Hepacivirus; Hepatitis C; HIV Seropositivity; Humans; Magnetic Resonance Imaging; Male; Manganese; Manganese Poisoning; Parkinson Disease, Secondary; Propiophenones; Substance Abuse, Intravenous | 2008 |
Studies on amyotrophic lateral sclerosis by neutron activation analysis. 3. Systematic analysis of metals on Guamanian ALS and PD cases.
Topics: Aged; Aluminum; Amyotrophic Lateral Sclerosis; Calcium; Central Nervous System; Copper; Dementia; Female; Guam; Humans; Male; Manganese; Metals; Middle Aged; Parkinson Disease, Secondary; Syndrome | 1982 |
Serum and urinary manganese levels in patients with Parkinson's disease.
Topics: Activities of Daily Living; Aged; Brain; Chromium; Cobalt; Female; Humans; Lipid Peroxidation; Male; Manganese; Metabolic Clearance Rate; Parkinson Disease; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors | 1995 |
Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate).
Topics: Humans; Male; Maneb; Manganese; Middle Aged; Occupational Exposure; Parkinson Disease, Secondary | 1994 |
Urinary excretion of homovanillic acid in workers exposed to manganese.
Topics: Adult; Dust; Environmental Monitoring; Homovanillic Acid; Humans; Male; Manganese; Maximum Allowable Concentration; Middle Aged; Occupational Diseases; Occupational Exposure; Parkinson Disease, Secondary; Risk Factors | 1993 |
Progression after chronic manganese exposure.
Topics: Adult; Chronic Disease; Follow-Up Studies; Humans; Levodopa; Male; Manganese; Middle Aged; Movement Disorders; Nervous System Diseases; Occupational Exposure; Parkinson Disease, Secondary | 1993 |
Long-term progression in chronic manganism: ten years of follow-up.
Topics: Chronic Disease; Disease Progression; Follow-Up Studies; Gait; Humans; Manganese; Manganese Poisoning; Middle Aged; Occupational Exposure; Osmolar Concentration; Parkinson Disease, Secondary; Time Factors | 1998 |
Manganese: a transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of parkinsonism.
Topics: Animals; Brain; Caudate Nucleus; Dopamine; Hydroxyl Radical; Iron; Lipid Peroxidation; Male; Manganese; Mesencephalon; Neostriatum; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Superoxide Dismutase | 1998 |
Manganese induced parkinsonism: a case report.
Topics: Humans; Male; Manganese; Middle Aged; Parkinson Disease, Secondary; Radiography; Tomography, Emission-Computed | 1998 |
Environmental toxins accelerate Parkinson's disease onset.
Topics: Age of Onset; Hazardous Substances; Humans; Manganese; Middle Aged; Occupational Diseases; Parkinson Disease, Secondary | 2001 |
The distribution of copper, zinc- and manganese-superoxide dismutase, and glutathione peroxidase messenger ribonucleic acid in rat basal ganglia.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Basal Ganglia; Copper; Disease Models, Animal; Glutathione Peroxidase; Male; Manganese; Parkinson Disease; Parkinson Disease, Secondary; Rats; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Zinc | 2002 |
Preclinical neurophysiological signs of parkinsonism in occupational manganese exposure.
Topics: Adult; Electroencephalography; Evoked Potentials, Auditory; Evoked Potentials, Auditory, Brain Stem; Humans; Male; Manganese; Metallurgy; Middle Aged; Movement; Occupational Diseases; Parkinson Disease, Secondary; Reference Values | 1992 |
Manganese as possible ecoetiologic factor in Parkinson's disease.
Topics: Cohort Studies; Humans; Manganese; Occupational Exposure; Parkinson Disease; Parkinson Disease, Secondary | 1992 |
Chronic occupational exposure to manganese and neurobehavioral function.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Humans; Male; Manganese; Manganese Poisoning; Middle Aged; Neurologic Examination; Neuropsychological Tests; Occupational Diseases; Occupational Exposure; Parkinson Disease, Secondary; Substance-Related Disorders | 1991 |
Dopa-responsive parkinsonism with normal 6[18F]-fluorodopa positron emission tomography scans.
Topics: Corpus Striatum; Fluorine Radioisotopes; Humans; Levodopa; Manganese; Parkinson Disease, Secondary; Substantia Nigra; Tomography, Emission-Computed | 1990 |
Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter.
Topics: Adult; Disease Outbreaks; Equipment Failure; Female; Humans; Male; Manganese; Metallurgy; Middle Aged; Occupational Diseases; Parkinson Disease, Secondary; Taiwan; Ventilation | 1989 |
[The organic psychosyndrome in electric arc welders. A possible sequela of manganese toxicity].
Topics: Brain; Humans; Manganese; Mental Disorders; Middle Aged; Occupational Diseases; Parkinson Disease, Secondary; Syndrome; Welding | 1987 |
Chronic enteral poisoning caused by potassium permanganate: a case report.
Topics: Aged; Gastrointestinal Diseases; Humans; Male; Manganese; Medication Errors; Parkinson Disease, Secondary; Pentetic Acid; Potassium Permanganate | 1986 |
Tyrosine hydroxylase and parkinsonism.
Topics: Animals; Brain; Carbon Monoxide; Catecholamines; Dopamine; Haplorhini; Humans; Manganese; Mixed Function Oxygenases; Parkinson Disease; Parkinson Disease, Secondary; Serotonin; Substantia Nigra; Tyrosine | 1971 |